Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. Els Janssens

No current affiliation with UGent

Add to list
- Conference Paper
- C3
The value of baseline chest CT scan for the diagnosis of ipa in patients with AML treated with intensive chemotherapy : a retrospective single-centre cohort study

Els Janssens (UGent) , Sammy Huygens, Ine Moors (UGent) , Tessa Kerre (UGent) , Anke Delie (UGent) , Lieve Morbée (UGent) , Jerina Boelens (UGent) and Alexander Schauwvlieghe (UGent)

(2022) BONE MARROW TRANSPLANTATION. In Bone Marrow Transplantation 57(Supplement 1). p.266-267
Add to list
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex

Geertrui Denecker (UGent) , Shana Claeys (UGent) , Irina Lambertz (UGent) , Els Janssens (UGent) , Suzanne Vanhauwaert (UGent) , Bieke Decaesteker (UGent) , Tom Van Maerken (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Kristina Althoff, et al.

(2017) AACR annual meeting 2017. In Annual meeting of the American Association for Cancer Research : proceedings 58. p.1484-1484
Add to list
- Conference Paper
- C3
The HBP1 tumour suppressor is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex

Shana Claeys (UGent) , Geertrui Denecker (UGent) , Bieke Decaesteker (UGent) , Els Janssens (UGent) , Candy Kumps (UGent) , Sara De Brouwer (UGent) , Irina Lambertz (UGent) , Annelies Fieuw (UGent) , Suzanne Vanhauwaert (UGent) , Kristina Althoff, et al.

(2017) f-Tales, Abstracts.
Add to list
- Conference Paper
- C3
HBP1 is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex

Shana Claeys (UGent) , Geertrui Denecker (UGent) , Irina Lambertz (UGent) , Els Janssens (UGent) , Suzanne Vanhauwaert (UGent) , Bieke Decaesteker (UGent) , Tom Van Maerken (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Kristina Althoff, et al.

(2017) Treatment and Research Center for Pediatric Oncology and Haematology Heidelberg, Opening symposium, Abstracts.
Add to list
- Conference Paper
- C3
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex

Shana Claeys (UGent) , Irina Lambertz (UGent) , Els Janssens (UGent) , Suzanne Vanhauwaert (UGent) , Bieke Decaesteker (UGent) , Candy Kumps (UGent) , Sara De Brouwer (UGent) , Annelies Fieuw (UGent) , Tom Van Maerken (UGent) , Bram De Wilde (UGent) , et al.

(2016) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
- Conference Paper
- C3
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex

Shana Claeys (UGent) , Irina Lambertz (UGent) , Els Janssens (UGent) , Suzanne Vanhauwaert (UGent) , Bieke Decaesteker (UGent) , Candy Kumps (UGent) , Sara De Brouwer (UGent) , Annelies Fieuw (UGent) , Tom Van Maerken (UGent) , Bram De Wilde (UGent) , et al.

(2016) OncoPoint, 4th Research seminar, Abstracts.
Add to list
- Conference Paper
- C3
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindner, Anneleen Beckers (UGent) , Els Janssens (UGent) , Daniel Carter, Alex Cazes, Belamy Cheung, Marilena De Mariano (UGent) , et al.

(2015) OncoPoint, 3rd Meeting, Abstracts.
Add to list
- Conference Paper
- C3
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindner, Anneleen Beckers (UGent) , Els Janssens (UGent) , Daniel Carter, Alex Cazes, Belamy Cheung, Marilena De Mariano (UGent) , et al.

(2015) Belgian Society of Human Genetics, 15th Annual meeting, Abstracts.
Add to list
- Conference Paper
- C3
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindner, Anneleen Beckers (UGent) , Els Janssens (UGent) , Daniel Carter, Alex Cazes, Belamy Cheung, Marilena De Mariano (UGent) , et al.

(2015) New trends in anticancer drug development, CNIO Frontiers Meeting, Abstracts.